Concepedia

Author

Robert W. Seabury

SUNY Upstate Medical UniversityORCID

Also Known As

R. W. Seabury, R.W. Seabury, Robert Seabury, Robert W Seabury, Robert W. Seabury

90

Publications

674

Citations

14

H-Index

24

Concepts

All Affiliations

SUNY Upstate Medical UniversityUpstate University HospitalState University of New YorkBinghamton UniversityPenn State Milton S. Hershey Medical Center
RW

About

Robert W. Seabury is an author at SUNY Upstate Medical University specializing in medicine, drug resistance, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

101

2

Pharmacology

2

2

70

3

Health Sciences

1

1

31

4

Neurology

1

1

31

5

Antibiotics

1

1

56

Robert W. Seabury

×

17

Publications

433

Citations

14

H-Index

YearCitations

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia

Bryan T. Mogle, Jeffrey M. Steele, Robert W. Seabury,

International Journal of Antimicrobial Agents

2018

56

Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?

Cory M. Hale, Robert W. Seabury, Jeffrey M. Steele,

Journal of Pharmacy Practice

2016

55

Unsuccessful treatment of methicillin-resistant <i>Staphylococcus aureus</i> endocarditis with dalbavancin

Jeffrey M. Steele, Robert W. Seabury, Catherine Hale,

Journal of Clinical Pharmacy and Therapeutics

2017

44

Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage*

Elizabeth A. Feldman, Gregory Meola, Stephanie Zyck,

Critical Care Medicine

2019

43

Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy

Cory M. Hale, Jeffrey M. Steele, Robert W. Seabury,

Journal of Pharmacy Practice

2017

33

Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis

Katie A Parsels, Robert W. Seabury, Stephanie Zyck,

The American Journal of Emergency Medicine

2022

31

The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant <i>Staphylococcus aureus</i> Infection

Andrew M. Stoessel, Cory M. Hale, Robert W. Seabury,

Journal of Pharmacy Practice

2018

22

Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program

Pegah Shakeraneh, Tasaduq Fazili, Dongliang Wang,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2020

19

Hospital Discharge: An Opportune Time for Antimicrobial Stewardship

Katie A Parsels, Wesley D. Kufel, Jeni Burgess,

Annals of Pharmacotherapy

2021

17

Y-site Incompatibility between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?

Wesley D. Kufel, Christopher D. Miller, Paul Johnson,

Hospital Pharmacy

2017

16

Page 1